Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 611-618

  Smits, G J ^a   McVey, M ^a   Cox, B F ^a   Perrone, M H ^a   Clark, K L ^a  

^a Rhône Poulenc Rorer ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [7 [[2 (3 CHLORO 2 THIENYL) 1 METHYLPROPYL]AMINO] 3H IMIDAZO[4,5 B] PYRIDYL 3 YL]CYCLOPENTANE CARBOXAMIDE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE RECEPTOR; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ACUTE DISEASE; ANIMALS; FEMALE; IMIDAZOLES; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PYRIDINES; RECEPTORS, PURINERGIC P1; SWINE; SWINE, MINIATURE;

EID: 0032423596     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 264:H1327-H1336.
2. Baxter GF and Yellon DM (1994) Ischaemic preconditioning of myocardium: A new paradigm for clinical cardioprotection? Br J Clin Pharmacol 38:381-387.
3. Boachie-Ansah G, Kane KA and Parratt JR (1993) Is adenosine an endogenous myocardial protective (antiarrhythmic) substance under conditions of ischemia? Cardiovasc Res 27:77-83.
4. Bullough DA, Magill M, Firestein GS and Mullane KM (1995) Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol 155:2579-2586.
5. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ and Rumberger JA (1995) Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol 25:567-573.
6. - generation, respectively. J Clin Invest 85:1150-1157.
7. Downey JM (1992) Ischemic preconditioning: Nature's own cardioprotective mechanism. Trends Cardiovasc Med 2:170-176.
8. Forman MB, Velasco CE and Jackson EK (1993) Adenosine attenuates reperfusion injury following regional myocardial ischemia. Cardiovasc Res 27:9-17.
9. Galinanes M, Mullane KM, Bullough D and Hearse DJ (1992) Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation 86:598-608.
10. Goto M, Miura T, Iliodoromitis EK, O'Learu EL, Ishimoto R, Yellon DM and Iimura O (1991) Adenosine infusion during early reperfusion failed to limit infarct size in a collateral deficient species. Cardiovasc Res 25:943-949.
11. Granger DN and Korthuis RJ (1995) Physiologic mechanisms of postischemic tissue injury. Ann Rev Physiol 57:311-332.
12. 1-receptors. Circulation 86:1310-1316.
13. Gurden MF, Coates J, Ellis F, Evans B, Foster M, Hornby E, Kennedy I, Martin DP, Strong P, Vardey CJ and Wheeldon A (1993) Functional characterization of three adenosine receptor subtypes. Br J Pharmacol 109:693-698.
14. Hearse DJ and Bolli R (1991) Reperfusion induced injury. Manifestations, mechanisms and clinical relevance. Trends Cardiovasc Med 1:233-240.
15. Homeister JW, Hoff PT, Fletcher DD and Lucchesi BR (1990) Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 82(2):595-608.
16. Jordan JE, Zhao Z, Sato H and Vinten-Johansen J (1997) Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280:301-309.
17. Kloner RA (1993) Does reperfusion injury exist in humans? JACC 21(2):537-545.
18. Kloner RA (1995) Preconditioning: A balanced perspective. Br Heart J 74:575-577.
19. Lee Y, Sheu J and Yen M (1995) BN-063, a newly synthesized adenosine A1 receptor agonist, attenuates myocardial reperfusion injury in rats. Eur J Pharmacol 279: 251-256.
20. 1 adenosine receptors in rabbit heart. Circulation 84:350-356.
21. Merkel L, Hawkins ED, Colussi D, Greenland BD, Smits GJ, Perrone MH and Cox BF (1995) Cardiovascular and antilipolytic effects of the adenosine agonist GR 79236. Pharmacology 51:224-236.
22. 99mTc Sestamibi imaging predicts subsequent mortality. Circulation 92:334-341.
23. Mullane K (1993) AICA riboside: The prototype adenosine regulating agent for reducing myocardial ischaemic injury. Cardiovasc Res 27:43-47.
24. Murry CE, Jennings RB and Reimer KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
25. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 123:332-338.
26. Olafsson B, Forman MB, Puett DW, Pou A, Cates CU, Friesinger GC and Virmani R (1987) Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135-1145.
27. Ovize M, Aupetit JF, Rioufol G, Loufoua J, André-Fouët X, Minaire Y and Faucon G (1995) Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol 269:H72-H79.
28. Parratt JR (1994) Protection of the heart by ischaemic preconditioning: Mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 15:19-25.
29. Pelleg A and Porter RS (1990) The pharmacology of adenosine. Pharmacotherapy 10:157-174.
30. Schaer GL, Spaccavento LJ, Browne KF, Krueger KA, Krichbaum D, Phelan JM, Fletcher WO, Grines CL, Edwards S, Jolly MK and Gibbons RJ (1996) Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation 94:298-307.
31. 2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovas Pharm 22:89-96.
32. Schott RJ, Rohmann S, Braun ER and Schaper W (1990) Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66(4):1133-1142.
33. Schulz R, Rose J, Post H and Heusch G (1995) Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch 430:273-282.
34. Van de Werf F (1995) Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge? Circulation 91:2862-2864.
35. ATP channel. Am J Physiol 266:H829-H839.
36. Vander Heide RS and Reimer KA (1996) Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31:711-718.
37. Wainwright CL and Parratt JR (1993) Effects of R-PIA, a selective A1 adenosine agonist, on hemodynamics and ischaemic arrhythmias in pigs. Cardiovasc Res 27:84-89.
38. Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA and Cash WD (1987) Biochemical characterization of the triazoloquinazoline CGS15943, a novel non-xanthine antagonist. J Pharmacol Exp Ther 241:415-420.
39. Zhao ZQ, Nakanishi K, McGee DS, Tan P and Vinten-Johansen J (1994) A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia. Cardiovasc Res 28(2):270-279.